Effect of Recombinant Lactobacillus Expressing Canine GM-CSF on Immune Function in Dogs |
Chung, Jin-Young
(Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University)
Sung, Eui-Jae (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) Cho, Chun-Gyu (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) Seo, Kyoung-Won (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) Lee, Jong-Soo (Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California) Bhang, Dong-Ha (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) Lee, Hee-Woo (Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University) Hwang, Cheol-Yong (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) Lee, Wan-Kyu (Laboratory of Infectious Disease, College of Veterinary Medicine, Chungbuk National University) Youn, Hwa-Young (Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University) Kim, Chul-Joong (Laboratory of Infectious Disease, College of Veterinary Medicine, Chungnam National University) |
1 | Ashiuchi, M., K. Soda, and H. Misono. 1999. A poly--glutamate synthetic system of Bacillus subtilis IFO 3336: Gene cloning and biochemical analysis of poly--glutamate produced by Escherichia coli clone cells. Biochem. Biophys. Res. Commun. 263: 6-12 DOI ScienceOn |
2 | Jeong, K. J., J. H. Choi, W. M. Yoo, K. C. Keum, N. C. Yoo, S. Y. Lee, and M. H. Sung. 2004. Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli. Protein Expr. and Purif. 36: 150-156 DOI ScienceOn |
3 | Johnson-Henry, K. C., D. J. Mitchell, Y. Avitzur, E. Galindo-Mata, N. L. Jones, and P. M. Sherman. 2004. Probiotics reduce bacterial colonization and gastric inflammation in H. pyloriinfected mice. Dig. Dis. Sci. 49: 1095-1102 DOI ScienceOn |
4 | Metcalf, D. 1986. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factor. Blood 67: 257-267 PUBMED |
5 | Pouwels, P. H., R. J. Leer, and W. J. Boersma. 1996. The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigens. J. Biotechnol. 44: 183-192 DOI ScienceOn |
6 | Wang, J. M., S. Colella, P. Allavena, and A. Mantovani. 1987. Chemotactic activity of hunran recombinant granulocyte-macrophage colony-stimulating factor. Immunology 60: 439-444 PUBMED |
7 | Maassen, C. B., W. J. Boersma, C. van Holten-Neelen, E. Claassen, and J. D. Laman. 2003. Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: Implications for vaccine development. Vaccine 21: 2751-2757 DOI ScienceOn |
8 | Makino, S., I. Uchida, N. Terakado, C. Sasakawa, and M. Yoshikawa. 1989. Molecular characerization and protein analysis of the cap region which is essential for encapsulation in Bacillus anthracis. J. Bacteriol. 171: 722-730 PUBMED |
9 | Morrissey, P. J., L. Bressler, L. S. Park, A. Alpert, and S. Gillis. 1987. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139: 1113-1119 PUBMED |
10 | Weisbart, R. H., L. Kwan, D. W. Golde, and J. C. Gasson. 1987. Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69: 18-21 PUBMED |
11 | Cortes-Perez, N. G., L. G. Bermudez-Humaran, Y. Le Loir, C. Rodriguez-Padilla, A. Gruss, O. Saucedo-Cardenas, P. Langella, and R. Montes-de Oca-Luna. 2003. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol. Lett. 229: 37-42 DOI ScienceOn |
12 | Hammond, W. P., E. Csiba, A. Canin, H. Hockman, L. M. Souza, J. E. Layton, and D. C. Dale. 1991. Chronic neutropenia. A new canine model induced by human granulocyte colonystimulating factor. J. Clin. Invest. 87: 704-710 DOI PUBMED |
13 | Christensen, H. R., H. Frokiaer, and J. J. Pestka. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168: 171-178 PUBMED |
14 | Seegers, J. F. 2002. Lactobacilli as live vaccine delivery vectors: Progress and prospects. Trends Biotechnol. 20: 508-515 DOI PUBMED ScienceOn |
15 | Gerritse, K., M. Posno, M. M. Schellekens, W. J. Boersma, and E. Claassen. 1990. Oral administration of TNP-Lactobacillus conjugates in mice: A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli. Res. Microbiol. 141: 955-962 DOI ScienceOn |
16 | Villalta, F. and F. Kierszenbaum. 1986. Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (Trypanosoma cruzi) by human neutrophils. J. Immunol. 137: 1703-1707 PUBMED |
17 | Cortes-Perez, N. G., V. Azevedo, J. M. Alcocer-Gonzalez, C. Rodriguez-Padilla, R. S. Tamez-Guerra, G. Corthier, A. Gruss, P. Langella, and L. G. Bermudez-Humaran. 2005. Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J. Drug Target. 13: 89-98 DOI ScienceOn |
18 | Poo, H., H. M. Pyo, T. Y. Lee, S. W. Yoon, J. S. Lee, C. J. Kim, M. H. Sung, and S. H. Lee. 2006. Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int. J. Cancer 119: 1702-1709 DOI ScienceOn |
19 | Robinson, B. E., H. E. McGrath, and P. J. Quesenberry. 1987. Recombinant murine granulocyte-macrophage colony-stimulating factor has megakaryocyte colony stimulating activity and augments megakaryocyte colony stimulation by interleukin 3. J. Clin. Invest. 79: 1648-1652 DOI PUBMED ScienceOn |
20 | Warren, T. L. and G. J. Weiner. 2000. Uses of granulocytemacrophage colony-stimulating factor in vaccine development. Curr. Opin. Hematol. 7: 168-173 DOI ScienceOn |
21 | Gorbach, S. L. 1990. Lactic acid bacteria and human health. Ann. Med. 22: 37-41 DOI PUBMED ScienceOn |
22 | Kraehenbuhl, J. P. and M. R. Neutra. 1992. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Rev. 72: 853-879 PUBMED |
23 | Nathan, C. 1989. Respiratory burst in adherent human neutrophils. Triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73: 301-306 PUBMED |
24 | Schuening, F. G., R. Storb, S. Goehle, R. Nash, T. C. Graham, F. R. Appelbaum, R. Hackman, B. M. Sandmaier, and D. L. Urdal. 1989. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 17: 889-894 PUBMED |
25 | Metcalf, D., A. W. Burgess, G. R. Johnson, N. A. Nicola, E. C. Nice, J. DeLamarter, D. R. Thatcher, and J. J. Mermod. 1986. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: Comparison with purified native GM-CSF. J. Cell. Physiol. 128: 421-431 DOI PUBMED |
26 | Bermudez-Humaran, L. G.., N. G. Cortes-Perez, Y. Le Loir, J. M. Alcocer-Gonzalez, R. S. Tamez-Guerra, R. M. de Oca-Luna, and P. Langella. 2004. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J. Med. Microbiol. 53: 427-433 DOI ScienceOn |
27 | Amitage, J. O. 1998. Emerging applications of recombinant human granulocyte-macrophage colony-stimulation factor. Blood 92: 4491-4508 PUBMED |
28 | Herbst, B., G. Kohler, A. Mackensen, H. Veelken, and A. Lindemann. 1998. GM-CSF promotes differentiationof a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haematopoietic progenitor cells. Br. J. Haematol. 101: 231-241 DOI PUBMED ScienceOn |
29 | Strober, W. 1990. Regulation of IgA B-cell development in the mucosal immune system. J. Clin. Immunol. 10: 56S-61S DOI PUBMED |
30 | Ashiuchi, M., C. Nawa, T. Kamei, J. J. Song, S. P. Hong, M. H. Sung, K. Soda, and H. Misono. 2001. Physiological and biochemical characteristics of poly-y-glutamate synthetase complex of Bacillus subtilis. Eur. J. Biochem. 268: 5321-5328 DOI ScienceOn |
31 | Benson, E. B. and W. Strober. 1988. Regulation of IgA secretion by T cell clones derived from the human gastrointestinal tract. J. Immunol. 140: 1874-1882 PUBMED |
32 | Borrello, I. and D. Pardoll. 2002. GM-CSF-based cellular vaccines: A review of the clinical experience. Cytokine Growth Factor Rev. 13: 185-193 DOI ScienceOn |
33 | Fleischmann, J., D. W. Golde, R. H. Weisbart, and J. C. Gasson. 1986. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68: 708-711 PUBMED |
34 | Maliszewski, C. R., M. A. Schoenborn, D. P. Cerretti, J. M. Wignall, K. S. Picha, D. Cosman, R. J. Tushinski, S. Gillis, and P. E. Baker. 1988. Bovine GM-CSF: Molecular cloning and biological activity of the recombinant protein. Mol. Immunol. 25: 843-850 DOI ScienceOn |